Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Hematology
•
Antiphospholipid Syndrome
How would you manage a young male with high titer anticardiolipin and beta 2 glycoprotein IgM antibodies and TIA?
Lupus anticoagulant is absent
Related Questions
Do you avoid ESA use in patients with anemia and chronic kidney disease who also have APLS and risk for thrombosis?
Does a positive lupus anticoagulant alone confer high enough risk that warfarin is preferred over DOACs in antiphospholipid syndrome?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
How would you approach pursuing a kidney biopsy in a patient with suspected lupus nephritis who is on warfarin for antiphospholipid antibody syndrome?
How would you manage a patient with SLE that has a remote history of positive anti-phospholipid antibodies with a current DVT and now completely negative APLs?
Are you including Bortezomib as standard of care in the upfront treatment of T lymphoblastic-lymphoma?
When would you treat mild anemia from low testosterone in an older male?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
